Change Location × Mansfield, MA

    Recent Locations

      3D Bioprinting – a Powerful Emerging Technology for Research and Clinic in Mansfield

      • 3D Bioprinting – a Powerful Emerging Technology for Research and Clinic Photo #1
      1 of 1
      September 26, 2019

      Thursday  11:30 AM

      241 Francis Avenue
      Mansfield, Massachusetts 02048

      • No Performers Listed
      3D Bioprinting – a Powerful Emerging Technology for Research and Clinic

      The Mansfield Bio-Incubator  and ROKIT Healthcare invite you to a seminar and a networking event   Thursday, September 26, 2019    3D Bioprinting – a Powerful Emerging Technology for Research and Clinic   11:30 am- 1:30 pm at the Mansfield Bio-Incubator241 Francis AvenueMansfield, MA 02048 Directions:     Description:  As of July 2019, the US has approved reimbursement codes for point-of-care 3D printing devices. The hospital of the future will incorporate 3D printing to reduce costs and boost healthcare quality with personalized treatments.   The core of regenerative medicine lies in optimizing cell survival and adhesion, identifying the right biocompatible materials and ensuring biomimetic precision over the cellular architecture. 3D bioprinting provides ideal opportunities for the convergence of biomedical, engineering and clinical know-how’s to develop innovative tissue engineering approaches as well as personalized clinical solutions to today’s pressing health challenges.   This seminar presents the unique benefits of 3D bioprinting as a powerful tool for biomedical research as well as a translatable technology into the clinic. By combining automation and computer-aided design with the knowledge of structural organization and material composition of native tissues, bioprinting offers added values of precision, experimental repeatability, and architectural complexity to traditional tissue engineering that helps to create tissues with higher cell viability and functionality.   This seminar also introduces ROKIT’s work in the development of medical 3D bioprinting kits that combine the hardware, software, biomaterials, and protocols, which can be readily adopted by hospitals to treat patients and directly translate 3D printing combined with stem cell therapy into improved clinical outcomes.   Finally, the seminar reinforces the field of 3D bioprinting in the 4th industrial revolution as a movement aligned with global megatrends in healthcare toward personalized medicine, computer-aided production of biological processes, and autologous cell therapy.     Following the discussion, watch the 3D printer in action!     Who should attend: Life science entrepreneurs, health care providers and anyone else interested in learning more about 3D printing, specifically for biomedical applications.   Speaker:  Dr. Senthil Saravanumuthu   Dr. Senthil Saravanamuthu is the founder & CEO of ONS BIO LLC, distribution partner of Rokit Healthcare INVIVO bioprinters & HumaTein bioinks. He obtained his PhD in Biology from University of Hannover in Germany (2004) and did an extensive post-doctoral research training at the National Institutes of Health (NIH), Bethesda, MD (2004-2011) in cell molecular and development biology. In addition topassionately pursuing popularizing 3D bioprinting technologies, he also serves as director of business development & sales at Bio Basic since 2012, a leader in serving science.     About ROKIT Healthcare: ROKIT Healthcare is a global regenerative solutions company committed to providing an effective autologous organ regeneration platform using its proprietary 3D bio-fabrication technologies. In the life sciences research market, we supply clean-bench 3D bioprinters "INVIVO" as laboratory tools to advance research in tissue engineering, material science, and regenerative medicine. INVIVO is in 250+ labs in 24 countries, advancing research in tissue engineering, material engineering, drug testing, and 3D tissue and disease modeling. In the clinical market, we are in the development of 3D printing-based clinical platforms that provide personalized therapy in the areas of skin, cartilage, retina and heart patch regeneration. Below are our partners. In summary, ROKIT Healthcare is committed to accelerating the translation of the bioprinting technology from the bench to the clinic for improved patient care. ROKIT Healthcare is headquartered in Seoul, Korea with research bases in Boston, USA and Saarland, Germany. About INVIVO: INVIVO is a dual-module extrusion printer equipped with built-in sterilization systems, developed to allow researchers to pattern cells, biomolecules, and polymers to create complex 3D structures for life sciences reearch. It supports three types of printing technologies, including the syringe dispensers (-5 ~ 80C), filament extruders (RT ~ 250C), and hot-melt pneumatic dispensers (RT ~ 350C). Thanks to the three printhead technologies plus curing UV and temperature curing abilities, INVIVO enables soft-tissue and hard-tissue printing using a wide range of natural and synthetic polymers.    Our Sponsors and Partners:

      Categories: Business & Networking

      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.